MetLife Investment Management’s CRH CRH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.5M Sell
156,619
-4,189
-3% -$492K 0.08% 229
2025
Q4
$20.1M Buy
160,808
+149,497
+1,322% +$17.8M 0.1% 164
2025
Q3
$1.36M Buy
11,311
+13
+0.1% +$1.37K 0.01% 1288
2025
Q2
$1.04M Sell
11,298
-1,059
-9% -$96.6K 0.01% 1294
2025
Q1
$1.09M Buy
12,357
+283
+2% +$27.8K 0.01% 1321
2024
Q4
$1.12M Buy
12,074
+34
+0.3% +$3.27K 0.01% 1355
2024
Q3
$1.12M Sell
12,040
-271
-2% -$22.8K 0.01% 1336
2024
Q2
$923K Sell
12,311
-26,044
-68% -$2.08M 0.01% 1378
2024
Q1
$3.31M Sell
38,355
-1,985
-5% -$152K 0.02% 729
2023
Q4
$2.78M Buy
+40,340
New +$2.43M 0.02% 800

Other funds holding CRH

MetLife Investment Management's CRH Position: Q1 2026 in Review

MetLife Investment Management reduced its CRH (CRH) stake by 2.6% in Q1 2026, selling an estimated $492K and leaving 156,619 shares worth $16.5M. The position accounts for 0.08% of the portfolio, ranked #229.

MetLife Investment Management first reported a position in CRH in Q4 2023 and has held it in 10 quarters since. The position peaked at $20.1M in Q4 2025. 1,007 funds tracked by Wall St. Rank hold CRH as of Q1 2026.

  • MetLife Investment Management held 156,619 shares of CRH worth $16.5M as of Q1 2026.
  • MetLife Investment Management sold 4,189 CRH shares in Q1 2026, an estimated $492K.
  • CRH made up 0.08% of MetLife Investment Management's portfolio in Q1 2026, its #229 holding.
  • MetLife Investment Management first reported a position in CRH in Q4 2023 and has held it in 10 quarters since.
  • MetLife Investment Management's CRH position peaked at $20.1M in Q4 2025.
  • 1,007 funds tracked by Wall St. Rank held CRH as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.